Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€2.96
28.02.24
€11.06
28.02.25
-19.73%
03.07.24

Needham & Company LLC 
28.02.24 50%
buy
MannKind Corp.

Start price
Target price
Perf. (%)
€3.69
28.02.24
€5.99
28.02.25
33.44%
09:30

Cantor Fitzgerald 
28.02.24 50%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€71.00
28.02.24
€99.73
28.02.25
-28.17%
18:06

Needham & Company LLC 
28.02.24 50%
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€2.67
27.02.24
€7.38
27.02.25
-16.97%
13:09

Needham & Company LLC 
27.02.24 50%
buy
Krystal Biotech

Start price
Target price
Perf. (%)
€152.00
27.02.24
€179.60
27.02.25
17.11%
13:57

Citigroup Inc. 
27.02.24 50%
buy
Krystal Biotech

Start price
Target price
Perf. (%)
€152.00
27.02.24
€161.18
27.02.25
17.11%
13:57

Guggenheim 
27.02.24 50%
buy
Insmed Inc.

Start price
Target price
Perf. (%)
€26.80
27.02.24
€49.73
27.02.25
138.81%
08.07.24

Guggenheim 
27.02.24 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.42
27.02.24
€9.22
27.02.25
-55.59%
16:05

Barclays PLC 
27.02.24 50%
buy
Krystal Biotech

Start price
Target price
Perf. (%)
€148.00
27.02.24
-
27.02.25
20.27%
13:57

William Blair 
27.02.24 50%
buy
Insmed Inc.

Start price
Target price
Perf. (%)
€26.80
27.02.24
€42.39
27.02.25
138.81%
08.07.24

UBS Group AG 
27.02.24 50%
buy
AnaptysBio Inc

Start price
Target price
Perf. (%)
€24.80
26.02.24
€50.64
26.02.25
-4.84%
08.07.24

BTIG Research 
26.02.24 50%
sell
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€6.42
24.02.24
-
24.02.25
-55.42%
08.07.24

StockNews.com 
24.02.24 50%
buy
Acorda Therapeutics Cdt

Start price
Target price
Perf. (%)
€0.47
24.02.24
-
24.02.25
-
02.06.23

StockNews.com 
24.02.24 50%
buy
Corcept Therapeutics Inc.

Start price
Target price
Perf. (%)
€20.60
24.02.24
-
24.02.25
33.11%
09:30

StockNews.com 
24.02.24 50%
buy
Chromadex Corp

Start price
Target price
Perf. (%)
€1.39
24.02.24
-
24.02.25
64.03%
15:27

StockNews.com 
24.02.24 50%
buy
Glycomimetics Inc.

Start price
Target price
Perf. (%)
€2.66
24.02.24
-
24.02.25
-90.38%
09:30

Capital One Financial Co. 
24.02.24 50%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€64.80
23.02.24
€93.28
23.02.25
1.85%
14:08

Cantor Fitzgerald 
23.02.24 50%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€64.80
23.02.24
€79.43
23.02.25
1.85%
14:08

Royal Bank of Canada 
23.02.24 50%
buy
Dynavax Technologies Corp

Start price
Target price
Perf. (%)
€11.79
23.02.24
-
23.02.25
-12.39%
18:11

William Blair 
23.02.24 50%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€63.50
23.02.24
€75.68
23.02.25
3.94%
14:08

Needham & Company LLC 
23.02.24 50%
buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€1.24
22.02.24
€13.86
22.02.25
-40.08%
26.06.24

HC Wainwright 
22.02.24 50%
buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€41.40
22.02.24
€46.19
22.02.25
-2.42%
08.07.24

Needham & Company LLC 
22.02.24 50%
buy
AnaptysBio Inc

Start price
Target price
Perf. (%)
€23.40
21.02.24
€46.24
21.02.25
0.00%
08.07.24

Stifel Nicolaus 
21.02.24 50%
buy
Prothena Corp. plc

Start price
Target price
Perf. (%)
€25.20
20.02.24
€73.90
20.02.25
-25.79%
05.07.24

Oppenheimer Holdings Inc. 
20.02.24 50%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€69.40
19.02.24
€85.00
30.09.25
-4.90%
14:08

Could be very worthwhile Investment >20% year
BiotechBee 
19.02.24 70%